Abstract
The national and international demand for stem cell lines of varying origins (eg human embryonic, induced pluripotent, somatic) and grades (eg research, clinical) is growing. This is in response to the expectation that stem cell science will radically improve our ability to understand and treat disease, to develop model systems of drug development, and to generate novel clinical therapies. A sustainable supply of stem cell lines that are scientifically and ethically sourced is both a practical and legal prerequisite for the continued progression of stem cell research towards clinical therapies. To this end, stem cell banks have become an invaluable resource, providing access to ethically sourced stem cell lines that meet high quality and safety standards.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 35-39 |
| Number of pages | 5 |
| Journal | Drug Discovery World |
| Volume | 13 |
| Issue number | 2 |
| State | Published - Mar 2012 |
| Externally published | Yes |
ASJC Scopus subject areas
- Drug Discovery